View all IQVIA events
WHO WE HELP
-
Pharmaceutical Manufacturers
-
MedTech
-
Emerging Biopharma
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialties
-
Patient Organizations
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
MedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover Innovations
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialties
Embrace digital innovation in healthcare and transform your organization with a suite of cutting-edge registry solutions.
EXPLORE SOLUTIONS
Patient Organizations
Maximize your patient impact with expert guidance, data-driven insights, and a suite of cutting-edge patient data solutions.
DRIVE PATIENT IMPACTU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
Webinar
"Collaborative Intelligence: Empowering the Human-AI Workforce in Life Sciences
REGISTER NOWWebinar
Evolving Patient Access and Spending on Medicines in the U.S.: GLP-1s, Oncology, Immunology, and Vaccines
September 11, 2025
Calendar
10:00am - 11:30am
Eastern
In 2024, the U.S. healthcare system saw significant shifts in medicine use, patient access, and spending - driven by the growing impact of GLP-1s, targeted oncology therapies, immunologics, and changing vaccination trends.
Join the IQVIA Institute for a data-rich, forward-looking discussion on how clinical innovation is reshaping the treatment landscape - and what this means for affordability, equity, and access in the years ahead.
Who Should Attend:
This session is designed for senior leaders and decision-makers across:
- Pharmaceutical and biotech companies (Market Access, Commercial Strategy, Medical Affairs, HEOR)
- Payers and managed care organizations
- Health systems and integrated delivery networks
- Health policy and public sector agencies
- Investment and advisory firms focused on biopharma innovation
What You’ll Learn:
- Key drivers of medicine use and spending in 2024 across GLP-1s, oncology, immunology, and vaccines
- How novel therapies are reshaping patient access—and the barriers that remain
- What’s ahead for U.S. healthcare spending with the rise of biosimilars, generics, and continued GLP-1 adoption
- Trends in health equity and utilization across geographies and populations
- Strategic implications for payers, providers, and innovators navigating this evolving landscape
Don’t miss this opportunity to gain timely insight into the future of U.S. medicine use and access.